Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression
Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression
Recruiting · NCT06510894 · Registry updated 2026-01-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression | Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, cardiac sarcoidosis, immune system disorder, lymphatic system disorder, lymphoproliferative syndrome, sarcoidosis | Recruiting | Not stated | 2026-01-07 | NCT06510894 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Pennsylvania | Philadelphia | United States | 507 |